Nathan L. Kleinman, PhD

This retrospective analysis explored the impact of infertility health benefit design on the use of infertility medications and procedures and pregnancy outcomes.

Employees with hepatitis C (HCV) who underwent existing treatments had more absences and higher indirect costs than HCVinfected employees who did not undergo treatment.

Antihypertensive medication adherence was associated with improvement in certain short-term utilization measures among employees with high prior medical costs.